Bausch Health’s four-year-old plan to spin off eye-care subsidiary Bausch + Lomb is caught in a standoff between the pharmaceutical company’s top shareholders including Carl Icahn and Paulson & Co. and debtholders favoring a bankruptcy filing to fix its balance...
Robert “Kelly” Ortberg will need both strategic vision and an eye for detail as he tries to revamp a manufacturing giant that has been hobbled by production delays, factory flubs and quality lapses.
